BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27

• Press Releases

  Ciprocopan (NXP100) Receives Marketing Approval in China for the Treatment of Patients with PNH Previously Untreated with Complement Inhibitors

  July 23, 2026

   · 

  6 min read
• Press Releases

  Maverix Names Carla Jung Chief Executive Officer to Lead Next Phase of Growth

  July 23, 2026

   · 

  2 min read
• Press Releases

  Verastem Oncology to Report Second Quarter 2026 Financial Results on August 6, 2026

  July 23, 2026

   · 

  1 min read
• Press Releases

  Xeris Biopharma to Report Second Quarter 2026 Financial Results on August 6, 2026

  July 23, 2026

   · 

  1 min read
• Press Releases

  Modular Medical Announces Formation of Pivot Innovation Council and Appointment of Robert Gabbay, MD, PhD, FACP as Chairman

  July 23, 2026

   · 

  5 min read
• Press Releases

  Accord BioPharma Announces Commercial Availability of Denosumab Biosimilars OSVYRTI® (denosumab-desu) and JUBEREQ® (denosumab-desu)

  July 23, 2026

   · 

  19 min read
• Press Releases

  Precision Diabetes and Nagase Diagnostics Announce Exclusive U.S. Commercialization Partnership for Lucica® Glycated Albumin-L, the Only FDA-Cleared Assay Specifically Measured Glycated Albumin in the United States

  July 23, 2026

   · 

  7 min read
• Press Releases

  SimBioSys and Ferrum Health Partner to Expand Access to AI-Powered Surgical Planning Through Ferrum’s AI Governance Suite

  July 23, 2026

   · 

  3 min read
• Press Releases

  Bora Pharmaceuticals and Onconic Therapeutics Sign Manufacturing Agreement to Support U.S. Clinical Development of JAQBO Tablets

  July 23, 2026

   · 

  3 min read
• Press Releases

  Lantern Pharma Receives USPTO Notice of Allowance for Patent Covering Biomarker-Guided Treatment with LP-184 (Zirdafulven) in Multiple Solid Tumor Cancers

  July 23, 2026

   · 

  7 min read